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Abstract
Objectives: To evaluate the anti-inflammatory and analgesic effect of Bromelain (pineapple extract) administered 
orally in the postoperative after extraction of impacted lower molars.
Study Design: This is a prospective, placebo-controlled, unicentric, double-blind study; the sample size was 34 
patients. The pre and postoperative outcomes, evaluated on the third (D3) and eighth day (D8), included inflam-
tion, pain and oral aperture, as well as the need for analgesics. One group received bromelain 150mg per day for 
three days and 100mg on days 4 to 7. The other group received placebo in the same dosage. All outcomes wer-
recorded quantitatively and analyzed with the Mann-Whitney U test for independent samples.
Results: Although there were no statistically significant differences between the treatment groups, a trend towards 
less inflammation and improved oral aperture was observed in the group that received bromelain, compared to the 
group that received placebo. This trend can be attributed completely to random reasons, since there is no statistical 
difference in the results.
Conclusions: Further studies are necessary to analyze different administration patterns and doses of bromelain for 
the use in the postoperative of impacted third molars.
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Introduction
Bromelain (pineapple enzyme, Ananas comasus) is an 
aqueous extract obtained from the stem and fruit of the 
pineapple plant that contains high levels of proteolytic 
enzymes and which composition varies depending on 
the source and purification method (1,2). Bromelain 
directly influences pain mediators such as bradykinin 
(3), although its analgesic properties are closely linked 
to its anti-inflammatory properties (4,5). It has been-
shownthat this fibrinolytic agent promotes reabsorption 
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of edema in the blood circulation (6); it reduces swell-
ing, bruising, pain, and healing time after trauma and 
surgical procedures (5). Evidence has shown that bro-
melain digests fibrin, thus allowing the elimination of 
edema (7). Indirectly, bromelain increases the time re-
quired for the conversion of prothrombin into thrombin, 
and thus activating plasminogen into plasmin; by these 
means, it prevents the formation of fibrin (7). All these 
cause a reduction in vascular permeability. In addition, 
bromelain inhibits the synthesis of pro-inflammatory 
prostaglandins, particularly PGE2 (8).
The most common postoperative complications after 
the extraction of an impacted wisdom tooth are a di-
rect consequence of the inflammatory response to the 
surgical procedure (9) and include pain, inflammation 
and difficulty opening the mouth (10). Generally this re-
sponse is controlled with the surgical technique (11-16) 
and mainly with pharmacological anti-inflammatory 
measures (17,18).
The purpose of our study was to assess the effect of 
bromelain on inflammation, pain perception, and 
trismus,after the extraction of an impacted lower third 
molar, using a prospective double-blind clinical trial.
Material and Methods
-Subjects
34 healthy subjects,patients from the Faculty of Odon-
tology of the University of Seville (Spain) who needed 
the extraction of a lower third molar, were consecutive-
ly selected for the study. All the extractions were clas-
sified with a Koerner index (19) 5-6 (moderately dif-
ficult). This way, we excluded all candidates who met 
any exclusion criteria: allergy to any of the components 
used in the study;contraindication for the administra-
tion of adrenaline; psychiatric treatment; pregnancy or 
lactation; coagulation disorders or any treatment that 
may alter it; antibiotic treatment, analgesics or anti-
inflammatories used on the four days prior to the in-
tervention; active periodontitis; smoking more than ten 
cigarettes per day. The eligible patients were informed 
of the study and gave their consent. The University of 
Seville Research Ethics Committeeindependently ap-
proved the procedure.
-Surgical Procedure 
Articaine 4% with adrenaline 1:100.000was used as an-
esthetic. In all cases a bayonet incision with vertical dis-
charge was performed on the mesial half of the second 
molar;a mucoperiosteal flap was lifted, and osteotomy 
was performed with a number eight tungsten carbide 
bur mounted on a hand piece; the extraction was com-
pleted by drift. Odontosection was performed with tur-
bine and fissure bur, when needed.
The material used to suture the surgical wound was black 
braided silk 4/0, needle holder, toothless Adson forceps 
and scissors. The same operator performed all the inter-
ventions, and the same surgical material was used. The 
surgical protocol was not modified in any case.
-Pharmacological Treatment
It was decided to include a total of 40 patients in the 
study (20 per group), considering that the difference in 
inflammation marked on the third postoperative day 
would be 1.25 cm between the two groups, and estimat-
ing a variance of 2, with an alpha error of 0.05 (bila-
teral) and a beta error of 0.2.
For various reasons, the analysis was limited to 34 sub-
jects (Fig. 1). After maintaining the same alpha and beta 
errors, this sample size should be enough to identify a 
1.4 cm difference in swelling between the two groups, 
marked on the third postoperative day, and estimating a 
variance of 2.
The analysis was performed following a random and 
independent division on the side (right or left) into two 
groups: Test group (n = 16) and Control group (n = 18) 
(Fig. 1). All patients received the following medications: 
a) amoxicillin / clavulanate acid 875/125mg every 8 hours 
for 7 days, b) �aracetamol 500 mg (as first step rescue); 
Nolotil ® 575 mg (Boehringer Ingelheim, Spain, SA Sant 
Cugat del Valles, Barcelona) (as second step rescue). To 
assess the effect of bromelain, the tablets used in this tri-
alcontained 100 nkat, equivalent to 50mg of Ananas stem. 
The Test group was administered a regimen of three ta-
blets per day during the first three days and two tablets 
per day from the fourth to the seventh day. The Control 
Group was given placebo, three tablets a day for the first 
three days and two tablets a day from the fourth to the 
seventh day. When corticosteroid administration was re-
quired, following tooth extraction with a large osteotomy 
and / or long duration (over 30 minutes), the patient was 
excluded from the study due to the increased inflamma-
tion that both produce. In our study, two patients were 
excludedfor this reason; and two patients were excluded 
due to the administration of anti-inflammatory drugs that 
were not included in the study.
The randomization was performed through a rand-
omized list generated on a computer by the company 
Rothapharm, which used this randomization to prepare 
the pharmacological blisters of placebo or medication, 
with a blind design that did not allow the identification 
of any of them without access to the list; this access was 
only at the end of the study to analyze the data.
-Assessment of postoperative pain
�ostoperative pain was calculated using a Visual Ana-
logue Scale (VAS) of 10 cm in length, that is, a straight 
line with endpoints representing the sensation limits: 
no pain in one end and unimaginable pain at the other 
(20). The patient registered the pain values presented at 
the beginning of the study, on day 3 (D3) and on day 8 
(D8) postoperatively. We used a range of 0-10 (cm), with 
0 beingabsolute absence of pain and 10 the maximum 
degree of pain.
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Fig. 1. �onsort flow chart.
Fig. 2. Quantification method of oral aperture from mesial-incisal 
angle of lower central incisor to mesial-incisal angle of maxillary 
central incisor.
-Assessment of postoperative facial swelling
�ostoperative swelling was calculated using a Visual 
Analogue Scale (VAS) of 10 cm in length, that is, a 
straight line which endpoints represent the sensation 
limits: no swelling at one end and maximum swelling 
at the other (20). The patient registered the swelling val-
ues experienced at the beginning of the study (D0), on 
day 3 (D3) and on day 8 (D8) postoperatively. We used 
a range of 0-10 (cm), with 0 being absolute absence of 
swelling and 10 the maximum degree of swelling.
-Assessment of postoperative trismus
The degree of trismus was assessed by measuring the 
interincisal distance before surgery (D0), on the 3rd 
(D3), and 8th (D8) days postoperatively, with a specific 
ruler for oral aperture measurement (Therabite ®). The 
results are expressed in mm (Fig. 2).
-Statistical analysis
The data was analyzed using S�SS 17.0 software for 
Windows (LEAD Technologies, USA). Data analysis 
consisted of descriptive analysis (mean and standard 
deviation) of the quantitative variables (age, inflamma-
tion, pain and aperture). The differences between the 
two groups for each one of the variables was performed 
using the Mann-Whitney U test for independent sam-
ples with significant differences if p <0.05.
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Results
The total number of patients studied was 17 men and 
17 women with a mean age of 23.82 ± 3.9 years. In the 
control group 10 men and 7 women were treated, with 
an average age of 24.67 ± 4.2 years. In the experimental 
group 6 men and 11 womenwere treated, with a medi-
an age of 22.88 ± 3.6 years. Differences in age in both 
groups were not significant (p ≥ 0.05).
�reoperatively, the measurement of swelling, pain 
and aperture in both groups was similar, except for 
the inflammation which was slightly higher in the 
experimental group, although no statistically sig-
nificant differences existed (p <0.05) in any of them 
(Table 1).
Table 1 shows the results of the comparison between the 
control group and the test group on days 3 and 8, in the 
different postoperative outcomes. No significant diffe-
rences were observed in the assessment of pain between 
the two treatment groups.
Regarding measurement of the oral aperture, one can 
see that after D3 and specifically in the evaluation at 
the end of treatment on D8, there is a tendency to an 
increased aperture (3 mm more then the average) in the 
group receiving bromelain, although the results were 
not significant.
The biggest effect of bromelain was observed in inflam-
mation. Patients in the bromelain group, started from a 
slightly higher swelling values and at the end treatment, 
there was a slight tendency to a reduction in inflamma-
tion (0.65 ± 0.6 vs. 0.88 ± 0.8), not reaching statistical or 
clinical significance.
Regarding the postoperative use of analgesic medications 
by patients, there was an increase in the administration 
between days 1 and 3, after which there was a progressive 
decrease (Fig. 3).When comparing both study groups, we 
found no significant differences in the use of medication 
during the first eight postoperative days (although it was 
slightly lower in the control group).
Variables TestGroup ControlGroup p
Pain D0 0,281 ± 0,19 0,222 ± 0,08 N.S.
 D3 2,27 ± 2,5 2,00 ± 1,6 N.S.
 D8 0,50 ± 0,6 0,72  ± 0,5 N.S.
Aperture D0 51,75 ± 1,1 51,67  ± 1,7 N.S.
 D3 37,88 ± 10,7 37,78 ± 8,4 N.S.
 D8 46,63 ± 8,0 43,72 ± 9,2 N.S.
Inflammation D0 0,688 ± 0,35 0,250 ± 0,14 N.S.
 D3 4,18 ±2,810 5,19 ±2,901 N.S.
 D8 0,65 ±0,651 0,88 ±0,814 N.S.
Table 1. �reoperative (D0), and postoperative measurements (D3 = Day 3; D8 = day 8) in mm (mean ± d.e) 
in both study groups, comparisons by Mann-Whitney U test.
N. S. = not significant, p ≥ 0.05.
Fig. 3. Quantification method of oral aperture from mesial-incisal angle of lower central incisor to 
mesial-incisal angle of maxillary central incisor.
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Discussion
Several studies support the usefulness of orally admin-
istered bromelain to reduce pain and swelling after cer-
tain surgical procedures (4,5) due to a decreased level of 
certain pain mediators and vascular phenomena associ-
ated with acute inflammation (3,6).
�roteases, such as bromelain, act at specific points on 
the cell surface of the inflammatory component, specifi-
cally where their receptors are found, generating and / 
or destroying receptor agonists and activating and de-
activating them, so they contribute significantly in the 
signal transduction mechanism of the inflammation. 
However, this effect can be highly variable depending 
on the different levels of expression of these receptors, 
not only in different individuals, but also in different 
tissues of the same individual (21).
Most of the published studies suggest various types of 
mechanisms by which proteases, including bromelain, 
can decrease inflammation. Among them the most 
prominent are:
-Favoring the return of the interstitial fluid and inflam-
matory component cells into the bloodstream, and thus 
decreasing the swelling of the area (22)
-Decreasing the biosynthesisof plasmacinins and proin-
flammatory prostaglandins �GE2, �GF2 (23)
In our study we have evaluated the efficacy of bromelain 
in inflammation, pain and degree of oral aperture after 
the extraction of a lower third molar. Our results are 
consistent with those obtained by Hozt et al. (24) who 
evaluated the anti-inflammatory effect of bromelain 
after the extraction of third molars administering bro-
melain 80mg 3 times a day for 6 days. In our study we 
used an oral administration of 150 mg, whereas Hozt 
et al. used 240 mg. According to the published results, 
the administration of 150mg a day does not seem to be 
the most effective regimen; or at least it is less effective 
than the one used by Hozt et al.
Although the results obtained were similar between 
the two groups regarding pain and inflammation, they 
(24) obtained a reduced need for analgesic intake in the 
group that was administered bromelain. This last fact 
has not been confirmed in our study, as the use of medi-
cation in both groups was very similar.
On the other hand, Inchigolo et al. (25) compared the 
use of bromelain (40 mg every 6 hours for 6 days) with 
ketoprofen (100mg every 12 hours for six days, and 
found no differences between them. Therefore, they 
concluded that bromelain is as effective as an NSAID in 
the treatment of postoperative inflammation.
These differences between studies and the different 
anti-inflammatory effects obtained may be due largely 
to a lack of knowledge of the effective dosage adminis-
tration of bromelain indicated for postoperative inflam-
mation in the extraction of third molars. Although fur-
ther studies are required in this regard and various tests 
support the dose-dependent decrease in inflammation 
with bromelain (26), the analysis of these results seem 
to indicate a better response to third molar postopera-
tive inflammation with lower doses but less spaced in 
time (25), than higher doses (150mg) at longer intervals 
(24 hours), as is the case in this study.
In summary and based on the results obtained, we can 
conclude that:
- The oral administration of bromelain may have benefi-
cial effects in the control of postoperative inflammation 
and pain of impacted third molars, using an appropriate 
dose regimen, although this study has not highlighted 
these potential benefits.
- Further studies are needed to investigate the hypoth-
esis that different dosing regimens of bromelain may be 
associated with a greater anti-inflammatory effect in the 
postoperative management of impacted third molars.
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